SCHEMBL6473347

SCHEMBL6473347

NC(=O)Oc1ccc(F)c2c(C(=O)C(=O)N3CCN(C(=O)c4ccccn4)CC3)c[nH]c12

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 2/20 0.47
L3MBTL1 Q9Y468 2/20 0.46
CYP3A4 P08684 2/20 0.42
CYP2D6 P10635 2/20 0.42
KCNH2 Q12809 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C8 P10632 1/20 0.42
CYP2B6 P20813 1/20 0.42
CYP2C19 P33261 1/20 0.42
GAA P10253 2/20 0.40
PARP1 P09874 4/20 0.39
DPP4 P27487 1/20 0.39
DPP9 Q86TI2 1/20 0.39
RBP4 P02753 2/20 0.38
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
DRD2 P14416 1/20 0.36
CCR8 P51685 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6471735 0.88 CYP2D6 (0.53) CYP2C9L3MBTL1CYP3A4CYP2D6CYP2C19
SCHEMBL6441424 0.87 L3MBTL1 (0.49) CYP2C9L3MBTL1CYP3A4CYP2D6KCNH2
SCHEMBL6442045 0.87 CYP2C9 (0.56) CYP2C9L3MBTL1CYP3A4CYP2D6KCNH2
SCHEMBL6443089 0.84 L3MBTL1 (0.46) CYP2C9L3MBTL1CYP3A4CYP2D6KCNH2
SCHEMBL6443079 0.82 L3MBTL1 (0.46) CYP2C9L3MBTL1CYP3A4CYP2D6KCNH2
SCHEMBL6471347 0.81 CYP2C9 (0.51) CYP2C9CYP3A4CYP2D6KCNH2CYP1A2
SCHEMBL6442530 0.80 L3MBTL1 (0.43) CYP2C9L3MBTL1CYP3A4CYP2D6KCNH2
SCHEMBL6443103 0.79 L3MBTL1 (0.42) CYP2C9L3MBTL1CYP3A4CYP2D6KCNH2
SCHEMBL6442104 0.78 CYP2C9 (0.53) CYP2C9L3MBTL1CYP3A4CYP2D6KCNH2
SCHEMBL6441836 0.78 L3MBTL1 (0.41) CYP2C9L3MBTL1CYP3A4CYP2D6KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1299382-B1 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED INDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2005-09-21 EP claimed